Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets
Tussilagone is a sesquiterpenoid extracted from Tussilago farfara and is used as an oriental medicine for asthma and bronchitis. Although previous studies have shown that tussilagone has an inhibitory effect on platelet aggregation, no studies have been performed to investigate its precise effect on...
Main Authors: | Jing Zhou, Ru-Ping Yang, Wei Song, Hui-Min Xu, Yong-Hui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00380/full |
Similar Items
-
Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
by: Jia Li, et al.
Published: (2019-07-01) -
Tussilagone Inhibits the Inflammatory Response and Improves Survival in CLP-Induced Septic Mice
by: Yun Kyu Kim, et al.
Published: (2017-12-01) -
Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways
by: Xuantao Hu, et al.
Published: (2020-04-01) -
Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer
by: Sang-Hyeon Nam, et al.
Published: (2020-04-01) -
Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
by: Janina Jamasbi, RPh, et al.
Published: (2016-04-01)